Results 131 to 140 of about 31,541 (206)

Lipid profile dynamics and associated cardiovascular disease risk indices in Chinese people living with human immunodeficiency virus receiving antiretroviral therapy. [PDF]

BMC Infect Dis
Qiu L, Fang C, Chen F, Hu T, Tong X, Tu Z, Li Z, Wang L, Qi X, Yi L, Liu M, Zhang Z, Lu L.   +12 more
europepmc   +1 more source

Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children with HIV in the CHAPAS-4 trial. [PDF]

AIDS
Kamphuis AEM, Kiezebrink T, Waalewijn H, Bamford A, Szubert AJ, Chabala C, Bwakura-Dangarembizi M, Makumbi S, Nangiya J, Mumbiro V, Mulenga V, Musiime V, de Wildt SN, Colbers APH, Gibb DM, Burger DM, CHAPAS-4 trial team.   +16 more
europepmc   +1 more source

Persistent Seronegativity and Absence of Intact Proviruses Despite Prolonged Initial Viremia in Early-Treated Perinatal HIV Infection. [PDF]

Open Forum Infect Dis
Charre C, Buseyne F, Mélard A, Gardiennet E, Mariaggi AA, Montange T, Le Chenadec J, Warszawski J, Blanche S, Avettand-Fenoël V, Frange P.   +10 more
europepmc   +1 more source

Advancements in development of novel class of HIV protease inhibitors. [PDF]

Ann Med
Gu WG, Yin GZ, Zhang YP.
europepmc   +1 more source

Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir. [PDF]

In Vivo
Nakamaru Y, Sako KI, Ide N, Matsuda Y, Yamashita F, Maeda T.   +5 more
europepmc   +1 more source

Cartilage-protective effects of lopinavir/ritonavir: in vitro and in silico exploration of the HIF-1α/SOX9/IL-1β pathway. [PDF]

J Orthop Surg Res
Ozbek H, Yilmaz I, Akyuz A, Pehlivanoglu S, Sirin DY, Albayrak M, Yilmaz OF.   +6 more
europepmc   +1 more source

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19. [PDF]

Clin Transl Sci
Ben Ghezala I, Peiffer-Smadja N, Solas C, Nougairède A, Touret F, Bardou M.   +5 more
europepmc   +1 more source

AIDS patients suffer higher risk of advanced knee osteoarthritis progression due to lopinavir-induced Zmpste24 inhibition. [PDF]

Bone Res
Kong K, Liu L, Zhang R, Chang Y, Shao Y, Zhao C, Qiao H, Jin M, Chen X, Shi W, Wu X, Fan W, Hu Y, Rong K, Zhang P, Li B, Zhang J, Ma P, Zhang X, Li H, Zhai Z.   +20 more
europepmc   +1 more source

Nanoparticles in HIV treatment for improved drug delivery, clinical translation, and future direction. [PDF]

Discov Nano
Terkimbi SD, Dangana RS, Mbina SA, Paul-Chima UO, Aja PM, Mujinya R.   +5 more
europepmc   +1 more source

Nirmatrelvir-Ritonavir-Induced Pancreatitis: A Concern in the COVID Era. [PDF]

ACG Case Rep J
DeBroff J, Abraham J, Yoon BH, Cohen I.
europepmc   +1 more source